Data / Medical devices / Italy / IBSA Farmaceutici Italia Srl
IBSA Farmaceutici Italia Srl: FDA-registered device maker in Lodi (San Grato) Lombardy, Italy, 1 PMA approval
IBSA Farmaceutici Italia Srl is registered with the FDA (registration 3008280916) in Lodi (San Grato) Lombardy, Italy. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated May 9, 2014. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3008280916
- Address
- Via Martiri di Cefalonia 2, Lodi (San Grato) Lombardy, Italy, 26900
- Owner or operator
- IBSA Institut Biochimique SA (10051428)
- Roles
- Manufacturer
- First device listed
- March 16, 2016
- Registered through
- 2027
- Brand names listed
- Gelsyn-3
Devices it lists
| Device | Product code | Class | Role | Source |
|---|---|---|---|---|
| Acid, Hyaluronic, Intraarticular | MOZ | 3 | Manufacturer | accessdata.fda.gov |
PMA approvals
Premarket approvals this establishment lists, with the supplements the FDA has decided since.
| Approved | PMA number | Device | Product code | Supplements | Latest decision | Source |
|---|---|---|---|---|---|---|
| May 9, 2014 | P110005 | SINOVIAL (SODIUM HYALURONATE 0.8%) | MOZ | 14 | July 24, 2026 | accessdata.fda.gov |
Compare with other makers
Updated July 24, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.